Engitix is operates as a tissue engineering company.
Engitix has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Engitix's investors include Netherton Investments, DOMPE.
Engitix is headquartered in London, United Kingdom.
Engitix is operates as a tissue engineering company.
Engitix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Engitix — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/engitix. Accessed September 15, 2026.
VCBacked. (2026). Engitix — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/engitix
{{cite web |title=Engitix — Funding & Investors |url=https://www.vcbacked.co/company/engitix |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated